Advertisement

Advertisement

Most Viewed Videos
Josep Tabernero, MD, PhD, on Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: Pembrolizumab With or Without Chemotherapy vs Chemotherapy
Matteo Lambertini, MD, PhD, on Safety of Pregnancy After Treatment for BRCA-Mutated Breast Cancer
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Hope S. Rugo, MD, and Matteo Lambertini, MD, PhD, on the SOPHIA Trial in HER2-Positive Metastatic Breast Cancer: Chemotherapy Plus Margetuximab vs Trastuzumab
Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Frederick L. Locke, MD, on Innovative CAR-T Cell Therapies: The Patient Experience
Sara A. Hurvitz, MD, on HR+/HER2− Advanced Breast Cancer: MONALEESA-7 Trial on Endocrine Therapy With or Without Ribociclib
Brian I. Rini, MD, on Renal Cell Carcinoma: Results From the TIVO-3 Trial on Tivozanib vs Sorafenib
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies
Sagar Lonial, MD, on Multiple Myeloma: Sequencing Therapies
Kim N. Chi, MD, on Metastatic Castration-Sensitive Prostate Cancer: First Results From the TITAN Trial
Xavier Pivot, MD, PhD, on Early Breast Cancer: Results From the PHARE Trial
Kieron M. Dunleavy, MD, on B-Cell Malignancies: Novel-Novel Drug Combinations
Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents
Kerry A. Rogers, MD, on Chronic Lymphocytic Leukemia: Acalabrutinib With Obinutuzumab in Treatment-Naive and Relapsed or Refractory Disease
Mark K. Ferguson, MD, on Mitigating Frailty and Sarcopenia to Improve Treatment Outcomes
James L. Mohler, MD, on Managing Prostate Cancer: NCCN Guidelines Updates

Advertisement

Advertisement



;
Advertisement